Medications

New drug combinations found for resistant cancers

Sanger researchers have created the world's largest novel resource using systematic drug testing and genetics analyses to show new potential drug combinations for breast, colon, and pancreatic cancer.

Oncology & Cancer

New method predicts drug response of cancer patients

Researchers from Delft University of Technology and the Netherlands Cancer Institute (NKI) have developed an algorithm to predict patient response to anti-cancer drugs. This allows us to identify more rapidly if some drugs ...

Oncology & Cancer

Targeting MAPK6 offers potential therapeutic strategy for cancer

A team led by scientists at Baylor College of Medicine uncovered new evidence supporting a cancer-promoting role for enzyme MAPK6. The study, published in the journal Science Advances, shows that MAPK6 furthers cancer growth ...

Oncology & Cancer

Finding new targets for acute myeloid leukemia in children

Acute myeloid leukemia (AML) is the second most common leukemia diagnosed in children. It is hard to treat and can be fatal in some cases. While there have been some recent successes with genetically targeted therapies for ...

page 8 from 40